{"schema_version":"secwatch.filing_event.v1","accession":"0001051514-23-000003","form_type":"8-K","ticker":"SSKN","cik":"0001051514","company_name":"STRATA Skin Sciences, Inc.","filed_at":"2023-01-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:43.675572+00:00","generated_at":"2026-06-20T17:27:33.471422+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"STRATA inks exclusive Mexico distribution deal; targets $300M acne, psoriasis, vitiligo market","bullets":["Three-year exclusive agreement with MINO Labs for distribution of TheraClearX, VTRAC, and XTRAC in Mexico.","STRATA gains access to nearly $300 million market for acne, psoriasis, and vitiligo treatments.","80% of Mexico's population is affected by low to severe acne, according to the release.","MINO Labs brings 20 years of pharmaceutical industry experience and deep Central/Latin America expertise."],"urls":{"canonical":"https://secwatch.observer/filing/0001051514-23-000003","json":"https://secwatch.observer/filing/0001051514-23-000003.json","markdown":"https://secwatch.observer/filing/0001051514-23-000003.md","text":"https://secwatch.observer/filing/0001051514-23-000003.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1051514/000105151423000003/0001051514-23-000003-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1051514/000105151423000003/form_8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T17:27:33.471422+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}